ResMed Inc. Common Stock (NYSE:RMD):
National Sleep Survey Launch on “The Dr. Oz Show” to Determine America’s Sleep Score.
The company is up by 0.87% since yesterday’s close of $59.83.
Additionally ResMed Inc. Common Stock recently announced a dividend that was paid on Thursday the 22nd of September 2016. The dividend was $0.330 per share for the quarter or $1.32 on an annualized basis. The dividend yield was $2.06. The ex-dividend date was Tuesday the 16th of August 2016.
Shares last traded at $60.35 slightly below the 50 day moving average which is $63.95 and which is marginally lower than the 200 day moving average of $63.07. The 50 day moving average went down by -5.64% and the 200 day average went down $-2.72 or -4.32%.
The company’s P/E ratio is 24.63 and market capitalization is 8.50B. In the last earnings report the EPS was $2.45 and is expected to be $2.77 for the current year with 140,785,000 shares outstanding. Next quarter’s EPS is estimated at $0.71 and the next full year EPS is anticipated to be $3.06.
Several brokerage firms have provided guidance on the company. On September 29 the company was upgraded to “Buy” from “” in an announcement from Bank of America. On September 19 the stock rating was downgraded from “Overweight” to “Neutral” by analysts at JP Morgan.
On August 23, 2016 the stock rating was rated “Underperform” by Jefferies which was a cut from the previous “Hold” rating. On June 27 the company was set at “Underperform” according to a Needham report a cut from the previous “Hold” rating.
On April 28 the stock rating was upgraded from “Neutral” to “Neutral” and a price target of $57.00 was set in a report from Macquarie. On April 27 the company was downgraded from “” to “Neutral” with a current price target of $57.00 in a statement from Piper Jaffray.